ResaPura

ResaPura Lavorazione Canapa per conto terzi. Cosmetici cbd/cbg

08/03/2026

Cannabis For Chronic Pain

Chronic Pain Affects Nearly Half the Population. Science Is Looking Back to a Plant Humans Have Used for Thousands of Years.

New research examining Cannabis sativa and the body’s endocannabinoid system is helping explain why cannabinoids may help manage pain when many conventional treatments fail.

Chronic pain affects roughly 30–50 percent of people worldwide, and about 10–15 percent of patients do not respond well to existing therapies such as opioids or antidepressants.

These drugs can also cause serious side effects including dependence, tolerance, and sedation.

Researchers are increasingly studying how cannabis compounds interact with the endocannabinoid system, a natural biological network that helps regulate pain and inflammation.

After injury, the body produces signaling molecules such as anandamide (AEA) and 2-AG, which help reduce pain signals and inflammatory responses.

Compounds from cannabis appear to strengthen or mimic this system.

Cannabinoids like THC and CBD influence two major receptor systems

• CB1 receptors in the brain and spinal cord that regulate how pain signals travel through the nervous system

• CB2 receptors in immune cells and peripheral tissues that help reduce inflammation and neuroimmune activity

Scientists also discovered cannabinoids affect additional biological pathways involved in pain signaling, including TRPV1, TRPA1, TRPM8, PPAR, and GPR55 receptors.

Because cannabis interacts with multiple pain pathways at once, researchers are investigating its potential role in conditions such as

• Neuropathic pain
• Inflammatory pain
• Migraine
• Cancer related pain
• Endometriosis pain

A major focus now is the development of CB2 targeted therapies, which may reduce pain and inflammation without the strong brain effects seen with some traditional drugs.

As modern science continues to study the plant’s chemistry and mechanisms, cannabis is increasingly being explored as a multi pathway approach to chronic pain management.

Research is still ongoing, but understanding how cannabinoids interact with the body’s own pain control system may help open the door to safer and more effective treatments for millions of people living with chronic pain.

March 2026
SOURCE HERE ⬇️ & In Comments

https://www.sciencedirect.com/science/article/abs/pii/S2950199726001023

01/03/2026

For a long time, acidic cannabinoids were dismissed as unstable precursors. The assumption was simple - heat them, activate them, move on. But biology is rarely that shallow.
When we talk about THCa, CBDa, and CBGa, we mean molecules that occur in the plant in their native, biologically arranged state. They are not damaged versions of THC or CBD. They are the plant’s native chemistry, built with a carboxylic acid group that changes how they interact with enzymes, receptors, and transcription factors.
That extra molecular group matters.
It alters polarity, binding preference, and metabolic fate. Acidic cannabinoids do not chase CB1 in the same way neutral THC does. Instead, many of them interact with nuclear receptors such as PPARγ, inflammatory mediators such as COX enzymes, serotonin receptors such as 5-HT1A, and transient receptor channels, including TRPV1. That means they influence gene expression, inflammatory tone, and cellular signaling without driving intoxication.
In their acidic state, they often show strong anti-inflammatory and anti-proliferative activity in preclinical models. CBDa has demonstrated potent COX-2 modulation. THCa has shown activity at PPARγ and anti-nausea pathways. CBGa interacts with metabolic and inflammatory signaling networks that tie directly into the regulatory balance.
Here is where it gets powerful.
When used alone, acidic cannabinoids can exert targeted regulatory effects. When combined, they create layered modulation. One may influence serotonin signaling, another metabolic transcription, another inflammatory cascades. That stacking effect is not chaos - it is orchestration.
The ECS is designed for modulation, not overload. Acidic cannabinoids fit that design because they tend to regulate rather than overwhelm. They operate upstream and downstream of classical cannabinoid receptors, shaping tone rather than forcing outcome.
In their natural, biologically arranged form, these molecules are not incomplete. They are precise. Alone, they can influence key pathways. Combined, they can create broader regulatory harmony.
The future conversation is not about activating them through heat. It is about understanding how the acidic architecture itself contributes to restoring balance at the cellular and neuronal levels.
-Mike Robinson, The Researcher OG

11/02/2026

Sometimes “there’s nothing we can do” is just code for we’re not allowed to try.

Drayk didn’t get a hopeful prognosis. He got dismissed.

Nasal cancer. Visible lesion. Antibiotics that did nothing. The vet was clear: no conventional options.

So Drayk’s owners went rogue.

They used THC FECO mixed with coconut oil—applied directly in the nose, with small amounts swallowed—alongside serrapeptase, yunnan baiyao, and turmeric (with black pepper + ginger).

The response was fast.
The vet wasn’t optimistic… until two weeks later when he was shocked by the progress and told them not to stop.

By one month, the cancer was gone. Completely.

Drayk was groggy at first from the THC. That passed. The results didn’t.

The cancer never came back. He lived another 10 months cancer-free until he unfortunately passed from an unrelated issue (bloat).

This is a patient-reported outcome. Not a promise. Not a pitch. Just proof that the standard playbook isn’t the only one.

10/02/2026

Nel 2023 abbiamo stipulato una convenzione con l’UNIVERSITA' degli Studi di Messina – Dipartimento di Scienze Veterinarie 🏛️🐾 per la RICERCA sui nostri prodotti e sul ruolo dei fitocannabinoidi 🌱 nei processi di infiammazione e neuroinfiammazione negli animali da compagnia🐾.

https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1341396/full

Visti gli ottimi risultati ottenuti, la collaborazione è stata rinnovata dopo 10 mesi per avviare un nuovo studio sulla modulazione del dolore nell’osteoartrite cronica 🧪💚

https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1496473/full

Questo percorso rappresenta per noi uno dei principali motivi di orgoglio e ci spinge a guardare al futuro con maggiore fiducia 🚀✨

18/01/2026

A new study published by Pharmaceutics finds that the cannabis compound cannabidiol, better known as CBD, could enhance the effectiveness of certain chemotherapy drugs against glioblastoma multiforme, one of the most aggressive and difficult-to-treat forms of brain cancer. The research was conducted...

10/01/2026

Introducing CBGa into my AM routine became the inflection point. CBGA doesn’t directly activate CB1 or CB2 receptors; instead, it acts upstream, influencing enzyme signaling and receptor tone, which can allow CB1 receptors to repopulate and regain sensitivity over time. That biochemical shift matched what I noticed in my own system: the THC oil that had felt muted for months suddenly felt effective again at lower doses. The tolerance wall didn’t vanish instantly, but it softened enough that dosing became more efficient, more predictable, and, finally, worth the effort again.

Lowering tolerance meant I could use less THC while feeling more of the intended effects, getting the most out of the oil without constantly escalating the dose just to reach baseline symptom control. For someone balancing seizures and cancer, that kind of dose efficiency isn’t a luxury; it’s a lifeline. The unexpected twist was that Genevieve’s need for CBGA research didn’t just help her; it recalibrated me. That shift allowed the THC oil to act more meaningfully, especially for sleep and symptom relief, because the receptors were finally in a state to respond again.

What saved me wasn’t a new oil formula; it was restoring receptor tone so the old one could finally work like it was supposed to. Genevieve needed the science, but I needed the alignment, and both pointed to the same truth: when the ECS regains balance, tolerance lowers naturally, endogenous modulators increase, and plant-derived bioactives finally hit their stride again without fighting upstream friction.

That moment in 2016 didn’t just shape a protocol; it validated a principle. If the Master Regulator is out of tune, nothing downstream performs correctly. When it finds its tone, everything else follows suit. Genevieve may have needed CBGA, but the Master Regulator made sure I needed it too, and that shared need rewrote the outcome entirely.

And that’s the quiet revolution of acidic precursors in real time: restoring ECS Balance so the therapies you already trust can finally work at their best again.

-Mike Robinson, The Researcher OG

03/01/2026

Holding CBGa concentrate on top of THC Distillate with terps helps show the world what ECS Balance looks like with cannabinoids. If we’re going to use the ultra-strong natural plant THC, we need to offset that with ingestion of cannabinoids like CBGa and CBDa that help our Endocannabinoid System (ECS) to regain it’s equillibrium. This causes numbed receptors to fire up again, new ones to replace the old, and circulates our bodies' cannabinoids, aka endocannabinoids, throughout our bodies, allowing our own fuel to mix with that of the plants. Now that’s a dynamic duo if I’ve ever heard of one, plant and endocannabinoids working together to calm the storms of life.

CBGa - everyday! Let’s talk more about why you should be using it now.

-Mike Robinson, The Researcher OG

20/12/2025

Peripheral neuropathy is one of those conditions that does not always scream loud, but it never truly shuts up. Tingling, burning, numbness, electric pain, weakness, loss of temperature sense, and that constant reminder that the nerves are not communicating the way they should. For many patients, conventional medicine offers symptom management at best, often wrapped in drugs that dull the body while never addressing the underlying signaling breakdown.

This is where cannabinoids enter the conversation in a way that makes biological sense. The ECS, our Master Regulator, is deeply involved in peripheral nerve signaling, immune modulation, and pain perception. CB1 receptors are present along peripheral nerve pathways and influence how pain signals are transmitted to the brain, while CB2 receptors are heavily involved in immune response and neuroinflammation, two key drivers of neuropathic pain.

A well-known clinical trial published in 2015 in The Journal of Pain titled “Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual participant data” showed that cannabinoids significantly reduced neuropathic pain compared to placebo, even in patients who had failed multiple other treatments. Importantly, the study highlighted that cannabinoids worked differently from opioids or gabapentinoids, improving pain without completely disconnecting sensory awareness.

What makes cannabinoids unique in neuropathy is that they do not simply block pain. They modulate it. They influence ion channels, inflammatory signaling, and neurotransmitter release in damaged nerves, helping calm hyperexcitable pathways while supporting overall neural communication. Cannabinoids like THC, CBD, CBG, and CBGa each play different roles depending on the patient’s ECS tone, the cause of nerve damage, and the level of inflammation involved.

This explains why some patients experience reduced burning, improved sleep, and better motor control rather than just numbness. The goal is not to shut off the nerves. The goal is to restore functional signaling where possible and reduce the inflammatory noise that keeps nerves firing incorrectly.

Peripheral neuropathy is not a single disease, and there is no single cannabinoid answer. What works is respecting the complexity of the nervous system and working with it instead of against it. When cannabinoids are used to support ECS Balance rather than overwhelm receptors, patients often find relief that feels more natural and sustainable.

That is not masking symptoms. That is helping the nervous system remember how to communicate again. Reach out and let’s talk if you need information about cannabinoids and this issue.

-Mike Robinson, The Researcher OG

06/12/2025

Chronic back pain is one of those conditions that settles in and shapes a patient’s life from the moment they wake up. Muscles clamp down, nerves stay irritated, and inflammation becomes the background noise the body cannot quite turn off. When cannabinoids step in for this type of pain, they are not acting as simple painkillers. They are helping the ECS, our Master Regulator, regain control over the signaling loops that drive persistent discomfort.

A clear example comes from the study "Cannabinoid Receptor Agonists and Antagonists as Analgesics" (2020), which showed how cannabinoids influence pain transmission through both the CB1 and CB2 pathways. That work helped clarify why THC shifts the perception of pain while CBD, CBGa, and CBDa influence the chemical landscape that keeps nerves inflamed.

THC helps turn down the volume on those amplified nerve messages that travel from irritated spinal tissue to the brain. CBD and CBGa help the body regulate inflammatory processes that wrap tightly around the spine and create muscle guarding. When those tissues settle down, the nerves stop firing the same distress signal on a loop.

CBDa supports this from another angle by influencing inflammatory pathways that run through the soft tissues and joint structures of the back. The acids give the Master Regulator room to reorganize the pain response so the body stops chasing itself in circles. Mobility improves, tension drops, and the patient feels a return of internal steadiness instead of the familiar burn that pushes them into fatigue.

Every patient is different. Some rely on THC for function, while others stabilize with morning CBGa. What matters is that cannabinoids give the Master Regulator the tools it needs to reshape how pain signals flow. When the system can do its job, the relief feels natural, not forced, and chronic back pain loses the grip it held for far too long.

-Mike Robinson, The Researcher OG

Indirizzo

Viale 1 Maggio 5
Corinaldo

Orario di apertura

Lunedì 08:00 - 18:00
Mercoledì 08:00 - 18:00
Giovedì 08:00 - 18:00
Venerdì 08:00 - 18:00
Sabato 08:00 - 13:00

Telefono

+393287492711

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando ResaPura pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a ResaPura:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram